Frontiers in Psychiatry | Psychopharmacology

Editorial

Published on 30 Aug 2024

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders – volume II

in Psychopharmacology

Glenn Hartelius
Sherry-Anne Muscat
Lucie Bartova

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1471609

989 views

Original Research

Published on 30 Aug 2024

Does tolerance to ethanol-induced ataxia explain the sensitized response to ethanol?

in Psychopharmacology

Cheryl Reed
Tamara J. Phillips

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1418490

728 views

Case Report

Published on 29 Aug 2024

Case report: Personalizing the use of trazodone in real-world patients: a study of three cases of depression with comorbidities

in Psychopharmacology

Gianluca Rosso
Beatrice Benatti
Mauro Pettorruso
Gaia Sampogna
Carmine Tomasetti

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1362221

1,693 views

Original Research

Published on 23 Aug 2024

Network pharmacology- and molecular docking-based investigation on the mechanism of action of Si-ni San in the treatment of depression combined with anxiety and experimental verification in adolescent rats

in Psychopharmacology

Zhiping Li
Shimin Liang
Xulan Cui
Chongkun Shen
Zaibin Xu
Wei Chen
Mingan Wu
Chao Liang
Jinman Liu
Jiawen Huang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1414242

2,663 views
1 citation

Original Research

Published on 16 Aug 2024

Pulmonary embolism incidence among patient admitted under psychiatry department: a case-control study

in Psychopharmacology

Wanling Zhang
Dhirendra Paudel
Rui Shi
Junwei Yang
Jingwen Liu
Yanbin Jia

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1449963

1,141 views

Original Research

Published on 02 Aug 2024

Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System

in Psychopharmacology

Chao Mu
Li Chen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322939

4,304 views

Case Report

Published on 01 Aug 2024

Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report

in Psychopharmacology

Lubova Renemane
Elmars Rancans

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1456455

9,009 views
1 citation

Case Report

Published on 31 Jul 2024

Case report: two cases of rhabdomyolysis following esketamine treatment

in Psychopharmacology

René Zeiss
Melissa Schweizer
Bernhard Connemann
Kathrin Malejko

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1450092

1,465 views
1 citation

Case Report

Published on 16 Jul 2024

Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report

in Psychopharmacology

André Do
Vanessa Michaud
Jean-François Stephan
Miltiadis Moreau
Élise Benoît
Félix-Antoine Bérubé
Antoine Bibaud-De Serres
Alain Taillefer
Philippe Vincent

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1394962

4,081 views
1 citation

Original Research

Published on 15 Jul 2024

Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention

in Psychopharmacology

Rui Yang
Jin-Ling Wan
Chen-Qi Pi
Tian-Hui Wang
Xue-Quan Zhu
Shuang-Jiang Zhou

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421370

1,268 views
1 citation

Editorial

Published on 04 Jul 2024

Editorial: Exploring prevention strategies and treatment in addictive disorders

in Psychopharmacology

Sandra Montagud-Romero
Victoria Gómez-Murcia
Francisco José Fernández-Gómez
Cristina Núñez

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1432822

986 views

Original Research

Published on 04 Jul 2024

Association between benzodiazepine anxiolytic polypharmacy and concomitant psychotropic medications in Japan: a retrospective cross-sectional study

in Psychopharmacology

Masahiro Takeshima
Kazuhisa Yoshizawa
Masaya Ogasawara
Mizuki Kudo
Yu Itoh
Naoko Ayabe
Nana Shibata
Kazuo Mishima

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1405049

1,219 views
1 citation

Review

Published on 24 Jun 2024

Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review

in Psychopharmacology

Jenny J.W. Liu
Natalie Ein
Julia Gervasio
Clara Baker
Rachel Plouffe
Sonya Wanklyn
Amer M. Burhan
Brenda Lau
Emmanuel Abreu
Thomas Wasiuta

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1338581

2,716 views

Original Research

Published on 19 Jun 2024

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia

in Psychopharmacology

Júlio César Menezes Vieira
Edna Afonso Reis
Augusto Afonso Guerra
Helian Nunes de Oliveira
Cristina Mariano Ruas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421501

1,741 views

Original Research

Published on 18 Jun 2024

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

in Psychopharmacology

Tigran Makunts
Ruben Abagyan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1414622

1,717 views
1 citation

Original Research

Published on 11 Jun 2024

Nicotine and fluoxetine alter adolescent dopamine-mediated behaviors via 5-HT1A receptor activation

in Psychopharmacology

Menglu Yuan
Frances M. Leslie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1380123

1,646 views
3 citations

Navigation group

Articles

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders – volume II

Does tolerance to ethanol-induced ataxia explain the sensitized response to ethanol?

Case report: Personalizing the use of trazodone in real-world patients: a study of three cases of depression with comorbidities

Network pharmacology- and molecular docking-based investigation on the mechanism of action of Si-ni San in the treatment of depression combined with anxiety and experimental verification in adolescent rats

Pulmonary embolism incidence among patient admitted under psychiatry department: a case-control study

Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System

Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder: a case report

Case report: two cases of rhabdomyolysis following esketamine treatment

Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report

Increased antipsychotic drug concentration in hospitalized patients with mental disorders following COVID-19 infection: a call for attention

Editorial: Exploring prevention strategies and treatment in addictive disorders

Association between benzodiazepine anxiolytic polypharmacy and concomitant psychotropic medications in Japan: a retrospective cross-sectional study

Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

Nicotine and fluoxetine alter adolescent dopamine-mediated behaviors via 5-HT1A receptor activation